Avid Radiopharmaceuticals
Hui Xiong is a seasoned scientist with extensive experience in the pharmaceutical and research sectors. Currently serving as a Senior Research Advisor and Senior Chemist at Avid Radiopharmaceuticals since October 2012, Hui has previously held the positions of Senior Scientist and Scientist at AstraZeneca from 2006 to November 2012. Early career positions include Postdoc Researcher roles at the University of Pennsylvania and The Scripps Research Institute between 2003 and 2006. Hui Xiong earned a PhD in Organic Chemistry from the University of Minnesota (1998-2003) and a BS in Chemistry from Peking University (1994-1998).
This person is not in any teams
Avid Radiopharmaceuticals
1 followers
At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avid's pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages of pathological change; allowing early treatment and management of people at risk - perhaps before before symptoms of disease can develop.